SCHEMBL6178178

SCHEMBL6178178

CCc1ccc(C2CCCN2S(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 3/20 0.61
GAA P10253 2/20 0.50
NR3C2 P08235 1/20 0.50
PSEN1 P49768 1/20 0.50
PSEN2 P49810 1/20 0.50
APH1B Q8WW43 1/20 0.50
NCSTN Q92542 1/20 0.50
APH1A Q96BI3 1/20 0.50
PSENEN Q9NZ42 1/20 0.50
KDM4A O75164 1/20 0.48
USP2 O75604 1/20 0.48
CRHBP P24387 1/20 0.48
CRHR2 Q13324 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
SIRT5 Q9NXA8 1/20 0.48
FKBP1A P62942 2/20 0.47
HSD11B1 P28845 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HPGD P15428 1/20 0.46
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6178182 1.00 TRPA1 (0.61) TRPA1GAANR3C2PSEN1PSEN2
SCHEMBL6178577 0.91 TRPA1 (0.73) TRPA1GAANR3C2PSEN1PSEN2
SCHEMBL6178584 0.91 TRPA1 (0.73) TRPA1GAANR3C2PSEN1PSEN2
SCHEMBL6177461 0.89 TRPA1 (0.80) TRPA1GAAPSEN1PSEN2APH1B
SCHEMBL6177734 0.89 TRPA1 (0.80) TRPA1GAAPSEN1PSEN2APH1B
SCHEMBL6177742 0.89 TRPA1 (0.80) TRPA1GAAPSEN1PSEN2APH1B
SCHEMBL6177464 0.89 TRPA1 (0.80) TRPA1GAAPSEN1PSEN2APH1B
SCHEMBL6178575 0.89 PSEN1 (0.65) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178582 0.89 PSEN1 (0.65) TRPA1PSEN1PSEN2APH1BNCSTN
SCHEMBL6178096 0.84 PSEN1 (0.70) TRPA1GAANR3C2PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP claimed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP claimed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US claimed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO claimed
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
EP-1165510-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-02 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed
WO-2000058285-A1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2000-10-05 WO disclosed